Nuwellis, Inc. (NUWE)
0.7878
+0.01
(+0.88%)
USD |
NASDAQ |
Sep 08, 16:00
0.78
-0.01
(-0.99%)
Pre-Market: 08:06
Nuwellis Debt to Equity Ratio : -0.0978 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0978 |
| March 31, 2026 | 0.0993 |
| December 31, 2025 | 0.1247 |
| September 30, 2025 | 0.0979 |
| June 30, 2025 | -0.0489 |
| March 31, 2025 | 0.1374 |
| December 31, 2024 | 0.0835 |
| September 30, 2024 | 0.1887 |
| June 30, 2024 | -0.0957 |
| March 31, 2024 | 0.7993 |
| December 31, 2023 | 0.2367 |
| September 30, 2023 | 0.1046 |
| June 30, 2023 | 0.0789 |
| March 31, 2023 | 0.0681 |
| December 31, 2022 | 0.0796 |
| September 30, 2022 | 0.0739 |
| June 30, 2022 | 0.0616 |
| March 31, 2022 | 0.0523 |
| December 31, 2021 | 0.0454 |
| September 30, 2021 | 0.0056 |
| June 30, 2021 | 0.0087 |
| March 31, 2021 | 0.0094 |
| December 31, 2020 | 0.0208 |
| September 30, 2020 | 0.0193 |
| June 30, 2020 | 0.0436 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0523 |
| December 31, 2019 | 0.2246 |
| September 30, 2019 | 0.113 |
| June 30, 2019 | 0.0632 |
| March 31, 2019 | 0.0458 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 1.600 |
| March 31, 2016 | 0.8935 |
| December 31, 2015 | 0.6408 |
| September 30, 2015 | 0.4202 |
| June 30, 2015 | 0.3138 |
| March 31, 2015 | 0.1911 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| GlucoTrack, Inc. | -1.125 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.126M |
| Total Liabilities (Quarterly) | 11.17M |
| Shareholders Equity (Quarterly) | -2.045M |
| Current Ratio | 1.971 |
| Net Debt Paydown Yield | 3.33% |